Depletion of MSK1 has been shown to inhibit oestrogen (E2) or progesterone-induced breast cancer cell (T-47D) proliferation and tumour growth in hormone-dependent breast cancer xenografts (Reyes et al. 2014). Here, RPS6KA5 is linked to neoplasm.